| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/05/15 | 22 : 00 | PR Newswire (US) | Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/05/15 | 20 : 50 | IH Market News | U.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices Drop | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/05/15 | 20 : 13 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/05/15 | 20 : 00 | PR Newswire (US) | Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/05/15 | 05 : 05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/05/02 | 20 : 00 | PR Newswire (US) | Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/04/25 | 23 : 12 | PR Newswire (US) | Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/04/23 | 23 : 57 | PR Newswire (US) | Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/03/19 | 20 : 33 | IH Market News | Unilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and More | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/03/18 | 20 : 12 | IH Market News | Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/03/18 | 20 : 01 | PR Newswire (US) | Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/03/04 | 21 : 01 | PR Newswire (US) | Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/02/27 | 21 : 01 | PR Newswire (US) | Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/02/23 | 23 : 30 | GlobeNewswire Inc. | New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/02/16 | 23 : 30 | GlobeNewswire Inc. | New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/02/02 | 23 : 30 | GlobeNewswire Inc. | New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/02/01 | 23 : 33 | GlobeNewswire Inc. | New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/29 | 21 : 00 | PR Newswire (US) | Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/27 | 00 : 55 | GlobeNewswire Inc. | New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/23 | 21 : 01 | PR Newswire (US) | Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024 | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/22 | 20 : 15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/19 | 23 : 30 | GlobeNewswire Inc. | New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/17 | 21 : 01 | PR Newswire (US) | Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/05 | 23 : 30 | GlobeNewswire Inc. | New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2024/01/03 | 22 : 00 | PR Newswire (US) | Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2023/12/11 | 21 : 01 | PR Newswire (US) | Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2023/12/08 | 23 : 46 | GlobeNewswire Inc. | New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2023/12/07 | 23 : 20 | GlobeNewswire Inc. | New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2023/12/01 | 23 : 30 | GlobeNewswire Inc. | New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |
| 2023/11/24 | 23 : 30 | GlobeNewswire Inc. | New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT | NASDAQ:ACXP | Acurx Pharmaceuticals Inc |